XLRN is currently covered by 12 analysts with average potential upside of $14.56 (21.58%) backed by 163 price targets and 149 ratings. Documented since 14-Oct-2013. Analyst's average stock valuation to be materialised ratio is 81.62% with an average time for price targets to be met of 215.56 days.
Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 08-Oct-2021.
Highest price target for XLRN is 179, Lowest price target is 118, average price target is 148.5.
Currently, out of the existing stock ratings of XLRN - 11 which are a Buy (52.38%), 10 which are a Hold (47.62%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
180
$1.25 (0.70%)
180
1 years 5 months 16 days ago
0/4 (0%)
$34.21 (26.40%)
Buy
180
1 years 5 months 19 days ago
15/16 (93.75%)
$30.75 (50.54%)
213
Hold
179
$0.25 (0.14%)
1 years 5 months 23 days ago
8/10 (80%)
$-3.97 (2.29%)
153
Hold
180
$1.25 (0.70%)
135
1 years 5 months 23 days ago
7/8 (87.5%)
$10.64 (15.70%)
88
Buy
180
$1.25 (0.70%)
180
1 years 5 months 23 days ago
6/8 (75%)
$23.5 (28.00%)
200
What is XLRN(Acceleron Pharma Inc) average time for price targets to be met?
Which analyst has the current highest performing score on XLRN(Acceleron Pharma Inc) with a proven track record?
